Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 91

    1.

    Breast cancer risk-assessment models.

    Evans DG, Howell A.

    Breast Cancer Res. 2007;9(5):213. Review.

    PMID:
    17888188
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Assessing women at high risk of breast cancer: a review of risk assessment models.

    Amir E, Freedman OC, Seruga B, Evans DG.

    J Natl Cancer Inst. 2010 May 19;102(10):680-91. Epub 2010 Apr 28. Review.

    PMID:
    20427433
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.

    Metcalfe KA, Poll A, O'Connor A, Gershman S, Armel S, Finch A, Demsky R, Rosen B, Narod SA.

    Clin Genet. 2007 Sep;72(3):208-17.

    PMID:
    17718858
    [PubMed - indexed for MEDLINE]
    4.

    Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene.

    Finch A, Metcalfe K, Lui J, Springate C, Demsky R, Armel S, Rosen B, Murphy J, Elit L, Sun P, Narod S.

    Clin Genet. 2009 Mar;75(3):220-4.

    PMID:
    19263514
    [PubMed - indexed for MEDLINE]
    5.

    Assessing breast cancer risk and BRCA1/2 carrier probability.

    Culver J, Lowstuter K, Bowling L.

    Breast Dis. 2006-2007;27:5-20. Review.

    PMID:
    17917138
    [PubMed - indexed for MEDLINE]
    6.

    Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.

    Walker LC, Waddell N, Ten Haaf A; kConFab Investigators, Grimmond S, Spurdle AB.

    Breast Cancer Res Treat. 2008 Nov;112(2):229-36. Epub 2007 Dec 20.

    PMID:
    18095154
    [PubMed - indexed for MEDLINE]
    7.

    Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.

    Rebbeck TR, Kauff ND, Domchek SM.

    J Natl Cancer Inst. 2009 Jan 21;101(2):80-7. Epub 2009 Jan 13.

    PMID:
    19141781
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.

    Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Díez O, Alonso MC, Lazaro C, Blanco I, Sánchez-de-Abajo A, Caldés T, Blanco A, Graña B, Durán M, Velasco E, Chirivella I, Cardeñosa EE, Tejada MI, Beristain E, Miramar MD, Calvo MT, Martínez E, Guillén C, Salazar R, San Román C, Antoniou AC, Urioste M, Benítez J.

    Clin Cancer Res. 2008 May 1;14(9):2861-9.

    PMID:
    18451254
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer.

    Thirthagiri E, Lee SY, Kang P, Lee DS, Toh GT, Selamat S, Yoon SY, Taib NA, Thong MK, Yip CH, Teo SH.

    Breast Cancer Res. 2008;10(4):R59. Epub 2008 Jul 16.

    PMID:
    18627636
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers.

    Rebbeck TR, Domchek SM.

    Breast Cancer Res. 2008;10(4):108. Epub 2008 Jul 25.

    PMID:
    18710587
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    A breast cancer prediction model incorporating familial and personal risk factors.

    Tyrer J, Duffy SW, Cuzick J.

    Stat Med. 2004 Apr 15;23(7):1111-30. Erratum in: Stat Med. 2005 Jan 15;24(1):156.

    PMID:
    15057881
    [PubMed - indexed for MEDLINE]
    13.

    Can genetic testing guide treatment in breast cancer?

    Tutt A, Ashworth A.

    Eur J Cancer. 2008 Dec;44(18):2774-80. Epub 2008 Nov 20. Review.

    PMID:
    19027287
    [PubMed - indexed for MEDLINE]
    14.

    Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients.

    Lee E, McKean-Cowdin R, Ma H, Chen Z, Van Den Berg D, Henderson BE, Bernstein L, Ursin G.

    Breast Cancer Res. 2008;10(1):R19. Epub 2008 Feb 19.

    PMID:
    18284688
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation.

    Vaidyanathan K, Lakhotia S, Ravishankar HM, Tabassum U, Mukherjee G, Somasundaram K.

    J Biosci. 2009 Sep;34(3):415-22.

    PMID:
    19805903
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations.

    Metcalfe KA.

    Womens Health (Lond Engl). 2009 Jan;5(1):63-8. Review.

    PMID:
    19102642
    [PubMed - indexed for MEDLINE]
    17.

    Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.

    Lee E, Ma H, McKean-Cowdin R, Van Den Berg D, Bernstein L, Henderson BE, Ursin G.

    Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3170-8.

    PMID:
    18990759
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    Establishing a family risk assessment clinic for breast cancer.

    Mulsow J, Lee J, Dempsey C, Rothwell J, Geraghty JG.

    Breast J. 2009 Sep-Oct;15 Suppl 1:S33-8.

    PMID:
    19775328
    [PubMed - indexed for MEDLINE]
    19.

    Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers.

    Berrington de Gonzalez A, Berg CD, Visvanathan K, Robson M.

    J Natl Cancer Inst. 2009 Feb 4;101(3):205-9. Epub 2009 Jan 27.

    PMID:
    19176458
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study.

    Kotsopoulos J, Librach CL, Lubinski J, Gronwald J, Kim-Sing C, Ghadirian P, Lynch HT, Moller P, Foulkes WD, Randall S, Manoukian S, Pasini B, Tung N, Ainsworth PJ, Cummings S, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.

    Cancer Causes Control. 2008 Dec;19(10):1111-9. Epub 2008 May 29.

    PMID:
    18509731
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk